Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksActiveops Regulatory News (AOM)

Share Price Information for Activeops (AOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.00
Bid: 100.00
Ask: 102.00
Change: 3.00 (2.97%)
Spread: 2.00 (2.00%)
Open: 101.00
High: 104.00
Low: 104.00
Prev. Close: 101.00
AOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Application

7 Jun 2021 16:56

RNS Number : 0814B
ActiveOps PLC
07 June 2021
 

07 June 2021

ActiveOps Plc

("ActiveOps", the "Company, "the Group")

Blocklisting application

 

Application has been made for the admission of 43,500 ordinary shares of 0.1p each in the Company (the "Shares") to trading on the AIM market of the London Stock Exchange. The Shares are being reserved under a block listing and may be issued pursuant to the exercise of options granted under the September 2019 Tranche 3 option scheme.

On issue, the Shares will be fully paid and will rank pari passu in all respects with the Company's existing issued ordinary shares. It is expected that admission of the Shares will be effective on 11 June 2021.

For more information, please contact:

ActiveOps

Via Alma PR

Richard Jeffery, Chief Executive Officer

www.activeops.com

Patrick Deller, Chief Financial Officer

 

 

 

 

 

Investec Bank plc

+44 (0)20 7597 5970

Corporate Broking & PLC Advisory

 

Patrick Robb / David Anderson / Ben Griffiths

 

 

 

TMT Investment Banking

 

Sebastian Lawrence / Alisdair Brady

 

 

 

 

 

Alma PR

+ 44(0) 203 405 0205

Caroline Forde / Sam Modlin / Faye Calow

 

 

About ActiveOps

ActiveOps is a leader in Management Process Automation (MPA), providing a SaaS platform to large enterprises with complex and often global back-offices. The Group's software and embedded back-office operations management methodology enables enterprises to adopt a data-driven, scientific approach to organising work and managing capacity.

The Group's enterprise platform comprises Workware+, its MPA software platform, and AOM, the Group's operations methodology and framework for effective back-office management. Together, this combination of software and embedded methodology enables operations managers to balance the competing priorities of meeting service and quality standards while improving productivity and reducing cost .

The Group has over 160 employees, serving its global customer base of approximately 80 enterprise customers from offices in the UK, Ireland, USA, Australia, India and South Africa. The Group's customers are predominantly in the banking, insurance and business process outsourcing (BPO) sectors, including Nationwide, TD Bank, Anthem, Inc and DXC Technology. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSKZGGVKNDGMZM
12
Date   Source Headline
21st May 20243:02 pmRNSDirector/PDMR Dealing
21st May 20248:46 amRNSNotification of Major Holdings
21st May 20248:38 amRNSNotification of Major Holdings
24th Apr 20247:00 amRNSFull Year Trading Update and Notice of Results
19th Apr 20247:00 amRNSDirector/PDMR Dealing
17th Apr 20244:30 pmRNSHolding(s) in Company
3rd Apr 202410:52 amRNSGrant of Options
25th Mar 20247:00 amRNSSenior Leadership Team Appointments
18th Mar 20245:49 pmRNSDirector/PDMR Dealing
26th Feb 20245:58 pmRNSDirector/PDMR Dealing
20th Feb 202412:02 pmRNSDirector/PDMR Dealing
20th Feb 20247:15 amRNSHolding(s) in Company
30th Jan 202410:49 amRNSDirector/PDMR Dealing
19th Jan 20241:00 pmRNSDirector/PDMR Dealing
28th Dec 20233:32 pmRNSDirector/PDMR Dealing
19th Dec 202312:12 pmRNSDirector/PDMR Dealing
7th Dec 20237:00 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSBoard Succession Planning
27th Nov 20234:20 pmRNSDirector/PDMR Dealing
21st Nov 20233:55 pmRNSDirector/PDMR Dealing
14th Nov 20237:00 amRNSInterim Results
10th Nov 20237:00 amRNSNotice of Investor Presentation
8th Nov 20234:29 pmRNSDirector/PDMR Dealing
18th Oct 20234:59 pmRNSDirector/PDMR Dealing
18th Oct 20237:00 amRNSTrading Update and Notice of Half Year Results
28th Sep 202312:48 pmRNSResult of AGM
26th Sep 202311:52 amRNSDirector/PDMR Dealing
26th Sep 20237:00 amRNSLaunch of ControliQ Series 3
18th Sep 20233:01 pmRNSDirector/PDMR Dealing
5th Sep 20237:00 amRNSAppointment of Chief Financial Officer
24th Aug 20232:31 pmRNSDirector/PDMR Dealing
23rd Aug 20235:58 pmRNSPublication of Annual Report and Notice of AGM
18th Aug 20234:59 pmRNSDirector/PDMR Dealing
27th Jul 20231:54 pmRNSHolding(s) in Company
26th Jul 20232:16 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSDirector/PDMR Dealing
18th Jul 20233:46 pmRNSDirector/PDMR Dealing
4th Jul 20237:00 amRNSResults for the year ended 31 March 2023
28th Jun 20234:36 pmRNSDirector/PDMR Dealing
26th Jun 20237:00 amRNSNotice of Results and Investor Presentation
19th Jun 20233:13 pmRNSDirector/PDMR Dealing
25th May 202311:20 amRNSDirector/PDMR Dealing
19th May 20231:14 pmRNSDirector/PDMR Dealing
25th Apr 20237:00 amRNSFull Year Trading Update
24th Apr 20234:41 pmRNSDirector/PDMR Dealing
21st Apr 202311:45 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of new Chief Financial Officer
27th Mar 20231:14 pmRNSDirector/PDMR Dealing
21st Mar 20237:00 amRNSDirector/PDMR Dealing
27th Feb 20237:00 amRNSDirector/PDMR Dealing
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.